OHE is pleased to announce that biostatistician Dr Fraser Lewis has joined the team as Head of Statistics, leading our statistical research, consultancy and advisory activities. Fraser's principal areas of expertise are in statistical modelling of data from biomedical studies. His particular interests include methods of analyzing data from observational studies and graphical multivariate modelling
OHE’s Director, Professor Adrian Towse, has been elected President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) for the 2014–15 term and will serve on the ISPOR Board of Directors as President-elect during 2013-14.
Composed of academics and thought leaders from within and outside of the UK, OHE’s Policy Board has provided advice and guidance to the OHE on its research programmes since the 1960s. In April, Professor Sir Michael Rawlins and Professor Peter C Smith joined the group.
OHE is recruiting a highly motivated, experienced and energetic statistician to head its statistics function and contribute to its core activities. Applications must be received by Wednesday, 8 May 2013.
OHE is delighted to welcome Prof David Parkin as a visiting researcher at OHE over the coming months. A long-standing member of the EuroQol Group, Prof Parkin's expertise will provide valuable insights for OHE's current research programme around EQ-5D topics.
Professor George Teeling Smith OBE, who set up the Office of Health Economics in 1962 and served as its Director for three decades, died unexpectedly on 28 January 2013. OHE would not exist but for George, nor would it have thrived for 50 years without his foresight in establishing OHE with the Policy Board and Editorial Board arrangement.
Keeping up with the latest important information is a constant challenge -- made both easier and more difficult by the explosion in communication avenues. To ensure that OHE news is there when you need it, we have launched three new services. We invite you to follow us!
OHE is seeking a highly motivated, energetic economist to contribute to its research and consultancy activities. Our work covers a broad range of analyses into the economics and policy of (1) health care systems, (2) pharmaceutical and other life sciences industries, and (3) health technology assessment. Applications must be received by Monday, 24 September 2012.